000 01516 a2200421 4500
005 20250513000056.0
264 0 _c19801021
008 198010s 0 0 eng d
022 _a0306-5251
024 7 _a10.1111/j.1365-2125.1980.tb05847.x
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aGreen, J A
245 0 0 _aMeasurement of drug dosage intensity in MVPP therapy in Hodgkin's disease.
_h[electronic resource]
260 _bBritish journal of clinical pharmacology
_cMay 1980
300 _a511-4 p.
_bdigital
500 _aPublication Type: Journal Article
650 0 4 _aAdult
650 0 4 _aAntineoplastic Agents
_xadverse effects
650 0 4 _aAntineoplastic Combined Chemotherapy Protocols
650 0 4 _aBody Surface Area
650 0 4 _aBone Marrow Diseases
_xchemically induced
650 0 4 _aDose-Response Relationship, Drug
650 0 4 _aDrug Therapy, Combination
650 0 4 _aFemale
650 0 4 _aHodgkin Disease
_xdrug therapy
650 0 4 _aHumans
650 0 4 _aMale
650 0 4 _aMechlorethamine
_xadministration & dosage
650 0 4 _aPrednisolone
_xadministration & dosage
650 0 4 _aProcarbazine
_xadministration & dosage
650 0 4 _aSplenectomy
650 0 4 _aVinblastine
_xadministration & dosage
700 1 _aDawson, A A
700 1 _aFell, L F
700 1 _aMurray, S
773 0 _tBritish journal of clinical pharmacology
_gvol. 9
_gno. 5
_gp. 511-4
856 4 0 _uhttps://doi.org/10.1111/j.1365-2125.1980.tb05847.x
_zAvailable from publisher's website
999 _c6892875
_d6892875